1 April 2007

People who are at most risk of a fracture are those most likely to benefit from medicines for osteoporosis, according to the latest edition of NPS RADAR, a newsletter about medicines published by the National Prescribing Service Limited.

An in-depth article describes the possible side effects and benefits of using the osteoporosis medicine, alendronate. It is sold under the brand names Alendro and Fosamax.

“Although osteoporosis medicines reduce the risk, fractures may still occur,” Professor Terry Diamond, an expert in osteoporosis, said. “I recommend that you talk to your doctor about how to help prevent, or better manage fractures and osteoporosis.

“If you have a low risk of fracture, you are not likely to benefit from this medicine. Your doctor can work out your fracture risk by discussing your risk factors for osteoporosis and the need to measure your bone mineral density (BMD).

“Simple and effective lifestyle changes such as cutting your alcohol intake, stopping smoking, and doing regular exercise can help keep your bones strong and balance training can reduce your fracture risk,” he said.

Preventing falls is very important because many fractures (especially hip) are caused by falls, and the risk of falls increases with age. From today, an estimated 40,000 older Australians are eligible for subsidised BMD tests and medication for the prevention of fractures on the Pharmaceutical Benefits Scheme (PBS).

The changes to the PBS make it possible for people aged 70 years and over who have very low bone density to receive osteoporosis medicines on the PBS. Previously, a Medicare rebate for BMD testing and PBS treatment for osteoporosis was only available to people who already had a fracture.

For more information on your medicine, ask your doctor or pharmacist for a consumer medicine information (CMI) leaflet.

ENDS

National Prescribing Service Limited (NPS) is an independent, non-profit organisation for Quality Use of Medicines. We provide accurate, balanced, evidence-based information and services to help people choose if, when and how to use medicines to improve their health and well-being. We are member-based and work in partnership with health professionals, government, pharmaceutical industry and consumers. NPS is funded by the Australian Government Department of Health and Ageing.

NPS RADAR provides independent information about new medicines and changes to PBS listings important to GPs, pharmacists and other health professionals involved in primary care management of patients.